Interim FDG-PET has no value in selecting patients who require treatment modification in both early- and advanced-stage Hodgkin lymphoma: response to Adams and Kwee

被引：2
|
作者：
Dann, Eldad J. [1 ,2 ]
Paltiel, Ora [3 ]
机构：
[1] Rambam Hlth Care Campus, Haifa, Israel
[2] Technion, Rappaport Fac Med, Haifa, Israel
[3] Hadassah Hebrew Univ Med Ctr, Jerusalem, Israel
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2018年 / 183卷 / 01期
关键词：
Hodgkin lymphoma (HL); interim PET; CT (PET-2); radiation therapy (RT); early-stage Hodgkin lymphoma (early-HL); advanced-stage Hodgkin lymphoma (advanced-HL); ADAPTED TREATMENT; TRIAL; THERAPY; INTERGROUP; ABVD; CT;
D O I：
10.1111/bjh.14905
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：131 / 133
页数：3
相关论文
共 50 条
  • [21] EARLY INTERIM FDG-PET DURING INTESIFIED BEACOPP THERAPY FOR ADVANCED-STAGE HODGKIN DISEASE SHOWS A LOWER POSITIVE PREDICTIVE VALUE THAN DURING ABVD
    Fiore, F.
    Viviani, S.
    Luminari, S.
    Levis, A.
    Di Raimondo, F.
    Merli, F.
    Vitolo, U.
    Bolis, S.
    Federico, M.
    Gallamini, A.
    HAEMATOLOGICA, 2010, 95 : S18 - S18
  • [22] FDG-PET for assessment of early therapy response after 4 cycles of chemotherapy in advanced stage Hodgkin lymphoma
    Markova, J.
    Skopalova, M.
    Kobe, C.
    Klaskova, K.
    Zikavska, L.
    Polivka, J.
    Vernerova, Z.
    Kamaradova, K.
    Dedeckova, K.
    Kozak, T.
    ANNALS OF ONCOLOGY, 2008, 19 : 135 - 135
  • [23] Advanced stage Hodgkin lymphoma: The predictive value on treatment outcome of early FDG-PET scan is independent of and superior to IPS score.
    Gallamini, A.
    Hutchings, M.
    Rigacci, L.
    Specht, L.
    Merli, F.
    D'Amore, F.
    Nassi, L.
    Hansen, M.
    Vitolo, U.
    Kamper, P.
    Trentin, L.
    Stelitano, C.
    Di Raimondo, F.
    Sancetta, R.
    Luminari, S.
    Viviani, S.
    Iannitto, E.
    Levis, A.
    BLOOD, 2006, 108 (11) : 228B - 228B
  • [24] Treatment Reduction in Patients with Advanced-Stage Hodgkin Lymphoma and Negative Interim FDG-PET: Final Results of the International, Randomized, Phase 3 HD18 Trial by the German Hodgkin Study Group
    Kobe, C.
    Goergen, H.
    Fuchs, M.
    Eich, H. T.
    Baues, C.
    Diehl, V.
    Kuhnert, G.
    Drzezga, A.
    Dietlein, M.
    Engert, A.
    Borchmann, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S312 - S312
  • [25] EARLY INTERIM 18F-FDG PET IN EARLY AND ADVANCED STAGE HODGKIN'S LYMPHOMA: EVALUATION ON 304 PATIENTS
    Zinzani, P. L.
    Rigacci, L.
    Stefoni, V.
    Broccoli, A.
    Puccini, B.
    Gandolfi, L.
    Fanti, S.
    Castagnoli, A.
    Pellegrini, C.
    Quirini, F.
    Vaggelli, L.
    Derenzini, E.
    Argnani, L.
    Bosi, A.
    Baccarani, M.
    ANNALS OF ONCOLOGY, 2011, 22 : 160 - 160
  • [26] FDG-PET for treatment response assessment in advanced stage Hodgkin Lymphoma -: report on the 2nd interim analysis of GHSG trial HD15
    Eich, H. T.
    Kobe, C.
    Dietlein, M.
    Kriz, J.
    Zimmermann, C.
    Skripnitchenko, R.
    Pluetschow, A.
    Engert, A.
    Mueller, R. -P.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2008, 184 : 11 - 11
  • [27] Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses
    Gallamini, Andrea
    Patti, Caterina
    Viviani, Simonetta
    Rossi, Andrea
    Fiore, Francesca
    Di Raimondo, Francesco
    Cantonetti, Maria
    Stelitano, Caterina
    Feldman, Tatyana
    Gavarotti, Paolo
    Sorasio, Roberto
    Mule, Antonino
    Leone, Monica
    Rambaldi, Alessandro
    Biggi, Alberto
    Barrington, Sally
    Fallanca, Federico
    Ficola, Umberto
    Chauvie, Stephane
    Gianni, Alessandro Massimo
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 152 (05) : 551 - 560
  • [28] The use of FDG-PET to guide consolidative radiotherapy in patients with advanced-stage Hodgkin lymphoma with residual abnormalities on CT scan following ABVD chemotherapy
    Savage, K. J.
    Connors, J. M.
    Klasa, R. J.
    Hoskins, P.
    Shenkier, T. N.
    Gascoyne, R. D.
    Bhimji, S.
    Pickles, T.
    Benard, F.
    Wilson, D.
    Sehn, L. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [29] RAPID Trial Demonstrates Low Positive Predictive Value of Interim FDG-PET in Early-stage Hodgkin Lymphoma After Three Cycles of ABVD
    Fulbright, Joy M.
    Williams, Sarah E.
    Pahud, Barbara A.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2016, 38 (02) : 165 - 165
  • [30] Early Interim PET in Patients with Advanced-Stage Hodgkin's Lymphoma Treated within the Phase 3 GHSG HD18 Study
    Borchmann, Peter
    Goergen, Helen
    Kobe, Carsten
    Lohri, Andreas
    Greil, Richard
    Eichenauer, Dennis A.
    Zijlstra, Josee M.
    Markova, Jana
    Meissner, Julia
    Feuring-Buske, Michaela
    Huttmann, Andreas
    Dierlamm, Judith
    Sokler, Martin
    Krause, Stefan W.
    Eich, Hans
    Baues, Christian
    Kreissl, Stefanie
    Fuchs, Michael
    Dietlein, Markus
    Engert, Andreas
    BLOOD, 2017, 130
12345